Howard Lotsof

Howard Lotsof is widely recognized as an influential but contested figure in the recent history of Western engagement with iboga and the alkaloid ibogaine, derived from the West African shrub Tabernanthe iboga. Over the last decades of the 20th century and into the early 21st, Lotsof played a central role in translating anecdotal and experiential reports — including reports he himself publicized — about the capacity of ibogaine to interrupt opioid dependence and other substance-use patterns into a program of scientific and regulatory attention. His efforts combined public advocacy, facilitation of clinical research, and encounters between biomedical researchers and practitioners connected to the Gabonese Bwiti ceremonial tradition that uses iboga sacramentally.

Historically, Lotsof’s activism occurred at a moment when a broader Western interest in psychedelics and traditional healing plants was intersecting with rising concern about opioid addiction. He promoted clinical protocols, encouraged investigators to study safety and efficacy, and advocated for regulatory pathways that would permit investigational use and, potentially, approved treatments. He and allies pursued a variety of development strategies, including efforts to secure intellectual-property protections and to engage pharmaceutical and clinical infrastructures in the testing of ibogaine-based interventions. These activities helped push ibogaine from the margins of pharmacological curiosity into medical and policy conversations about addiction treatment.

Lotsof’s interventions had several consequential effects. Clinicians and addiction specialists began to explore controlled ibogaine protocols in clinical settings; small-scale studies were initiated to assess acute safety, pharmacology, and therapeutic outcomes. At the same time, anthropologists, ethnographers, and cultural-rights advocates raised concerns about extracting pharmacological claims from the ritual and communal contexts in which Bwiti communities have used iboga. Adherents and observers of Bwiti emphasized that the ceremonial efficacy of iboga is embedded within relational, musical, and moral frameworks, and many argued that isolating ibogaine’s pharmacology risks misrepresenting how healing is produced in Bwiti practice.

Lotsof’s advocacy also intersected with legal and public-health debates. Medical literature and regulators identified cardiac and other safety concerns associated with ibogaine, prompting some jurisdictions to restrict or prohibit its use while others allowed investigational programs or supervised clinical administration. The resulting patchwork of legal statuses shaped how Bwiti communities negotiated access to iboga, cultivation rights, and collaborations with external researchers. These negotiations involved questions about consent, benefit-sharing, intellectual property, and the potential commodification of a sacramental plant.

In contemporary accounts of Bwiti’s global presence, Lotsof is not treated as a religious leader but as a catalyst whose actions altered the terms of international engagement with Gabonese ritual practice. His legacy is mixed: credited by proponents with opening pathways for research and therapeutic experimentation, critiqued by some scholars and advocates for contributing to the decontextualization and commercialization of indigenous knowledge. The debates his work stimulated continue to inform ethical, clinical, and legal discussions about how biomedical science and ritual traditions should interact.